Literature DB >> 15269304

Homogeneous polymerase chain reaction nucleobase quenching assay to detect the 1-kbp deletion in CLN3 that causes Batten disease.

Paul G Rothberg1, Denia Ramirez-Montealegre, Sharon D Frazier, David A Pearce.   

Abstract

Batten disease is an autosomal recessive disorder also known as juvenile neuronal ceroid lipofuscinosis. The most common mutation for this disease is an approximately 1-kbp deletion in the CLN3 gene, which accounts for about 80 to 85% of the mutation load. We developed a rapid assay for this mutation using the PCR to produce amplicons that are detected by nucleobase quenching of the fluorescent signal from a probe labeled with a fluorescent dye. The probe overlaps the deletion breakpoint and is completely base paired to the mutant amplicon. However, three bases at the 5' end of the probe do not base pair with the wild-type amplicon. The alleles are distinguished by the different melting temperatures of the probe amplicon hybrids. Comparison of this new method with an allele-specific PCR and gel electrophoresis-based method showed 100% concordance in determination of the genotype for 30 specimens (11 homozygous mutant, 8 heterozygotes, and 11 homozygous normal). PCR followed by allele-specific melting curve analysis using nucleobase quenching has utility as a rapid method for detection of the most common mutation that causes Batten disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15269304      PMCID: PMC1867635          DOI: 10.1016/S1525-1578(10)60519-3

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  15 in total

1.  Allelic discrimination using fluorogenic probes and the 5' nuclease assay.

Authors:  K J Livak
Journal:  Genet Anal       Date:  1999-02

Review 2.  Neuronal ceroid lipofuscinoses in childhood.

Authors:  P Santavuori; L Lauronen; E Kirveskari; L Aberg; K Sainio; T Autti
Journal:  Neurol Sci       Date:  2000       Impact factor: 3.307

3.  Intrinsic deoxyguanosine quenching of fluorescein-labeled hybridization probes: a simple method for real-time PCR detection and genotyping.

Authors:  C P Vaughn; K S Elenitoba-Johnson
Journal:  Lab Invest       Date:  2001-11       Impact factor: 5.662

Review 4.  Molecular genetic testing for neuronal ceroid lipofuscinoses.

Authors:  N Zhong
Journal:  Adv Genet       Date:  2001       Impact factor: 1.944

5.  Rapid diagnostic test for the major mutation underlying Batten disease.

Authors:  I Järvelä; H M Mitchison; P B Munroe; A M O'Rawe; S E Mole; A C Syvänen
Journal:  J Med Genet       Date:  1996-12       Impact factor: 6.318

6.  Fluorescein-labeled oligonucleotides for real-time pcr: using the inherent quenching of deoxyguanosine nucleotides.

Authors:  A O Crockett; C T Wittwer
Journal:  Anal Biochem       Date:  2001-03-01       Impact factor: 3.365

7.  An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.

Authors:  Subrata Chattopadhyay; Masumi Ito; Jonathan D Cooper; Andrew I Brooks; Timothy M Curran; James M Powers; David A Pearce
Journal:  Hum Mol Genet       Date:  2002-06-01       Impact factor: 6.150

8.  A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease.

Authors:  Yoojin Kim; Denia Ramirez-Montealegre; David A Pearce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

9.  Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium.

Authors: 
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

Review 10.  The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease.

Authors:  Jill M Weimer; Elizabeth Kriscenski-Perry; Yasser Elshatory; David A Pearce
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 4.103

View more
  15 in total

1.  Females experience a more severe disease course in Batten disease.

Authors:  Jennifer Cialone; Heather Adams; Erika F Augustine; Frederick J Marshall; Jennifer M Kwon; Nicole Newhouse; Amy Vierhile; Erika Levy; Leon S Dure; Katherine R Rose; Denia Ramirez-Montealegre; Elisabeth A de Blieck; Jonathan W Mink
Journal:  J Inherit Metab Dis       Date:  2011-12-14       Impact factor: 4.982

Review 2.  [Genetics of neuronal ceroidlipofuscinoses. Aspects of genetic counseling].

Authors:  M N Preising; B Lorenz
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

3.  Quantitative telemedicine ratings in Batten disease: implications for rare disease research.

Authors:  J Cialone; E F Augustine; N Newhouse; A Vierhile; F J Marshall; J W Mink
Journal:  Neurology       Date:  2011-10-19       Impact factor: 9.910

Review 4.  Neurobehavioral features and natural history of juvenile neuronal ceroid lipofuscinosis (Batten disease).

Authors:  Heather R Adams; Jonathan W Mink
Journal:  J Child Neurol       Date:  2013-09       Impact factor: 1.987

5.  Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease).

Authors:  J M Kwon; H Adams; P G Rothberg; E F Augustine; F J Marshall; E A Deblieck; A Vierhile; C A Beck; N J Newhouse; J Cialone; E Levy; D Ramirez-Montealegre; L S Dure; K R Rose; J W Mink
Journal:  Neurology       Date:  2011-10-19       Impact factor: 9.910

6.  Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease).

Authors:  Heather R Adams; Christopher A Beck; Erika Levy; Rachel Jordan; Jennifer M Kwon; Frederick J Marshall; Amy Vierhile; Erika F Augustine; Elisabeth A de Blieck; David A Pearce; Jonathan W Mink
Journal:  Dev Med Child Neurol       Date:  2010-02-19       Impact factor: 5.449

7.  Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates.

Authors:  Elisabeth A de Blieck; Erika F Augustine; Frederick J Marshall; Heather Adams; Jennifer Cialone; Leon Dure; Jennifer M Kwon; Nicole Newhouse; Katherine Rose; Paul G Rothberg; Amy Vierhile; Jonathan W Mink
Journal:  Contemp Clin Trials       Date:  2013-04-26       Impact factor: 2.226

8.  Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer.

Authors:  Manish Kohli; Paul G Rothberg; Changyong Feng; Edward Messing; Jean Joseph; Sreevidya Sadasiva Rao; Allison Hendershot; Deepak Sahsrabudhe
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

9.  Standardized assessment of seizures in patients with juvenile neuronal ceroid lipofuscinosis.

Authors:  Erika F Augustine; Heather R Adams; Christopher A Beck; Amy Vierhile; Jennifer Kwon; Paul G Rothberg; Frederick Marshall; Robert Block; James Dolan; Jonathan W Mink
Journal:  Dev Med Child Neurol       Date:  2014-11-11       Impact factor: 5.449

Review 10.  Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye.

Authors:  Sara Bozorg; Denia Ramirez-Montealegre; Mina Chung; David A Pearce
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.